COLLABORATION AND CONSENSUS
IN THE SEARCH FOR A CURE

Since 2001, the International Myeloma Working Group's achievements have changed the landscape of myeloma research. This collaborative effort has brought about breakthroughs in treatment options and diagnostic systems that prolong lives. The IMWG consists of nearly 200 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects. Their work focuses on protocols to provide a more durable remission for myeloma patients while improving quality of life, and addressing the needs of both myeloma patients and the physicians who treat them.

IMWG Publications

  • Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group

    Whole Body Low Dose CT (WBLDCT) has important advantages as a first-line imaging modality for bone disease assessment in patients with plasma cell disorders and has been included in the 2014

  • Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries

    Latin American countries (LATAMC) represent a large fraction of patients treated for multiple myeloma (MM) worldwide. In order to understand the difficulty of access to anti-myeloma therapy in

  • Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group

    For decades, conventional skeletal survey (CSS) has been the standard imaging technique for multiple myeloma (MM). However, recently whole-body computed tomography (WBCT) has been implemented